Berenice Bilharinho Mendonca

Prof. Dr. Berenice Bilharinho Mendonca

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Cancer Cell
Verified
Journal Article
Closed access
SZSiyuan Zheng
Siyuan Zheng
ACAndrew D. Cherniack
Andrew D. Cherniack
NDNinad Dewal
Ninad Dewal
RMRichard A. Moffitt
Richard A. Moffitt
LDLudmila Danilova
Ludmila Danilova
TDTimothy Defreitas
Timothy Defreitas

14 February 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MTMilena Gurgel Teles
Milena Gurgel Teles
SBSuzy D.C. Bianco
Suzy D.C. Bianco
VBVinicius Nahime Brito
Vinicius Nahime Brito
ETEricka B. Trarbach
Ericka B. Trarbach
WKWendy Kuohung
Wendy Kuohung
ALAna Claudia Latronico
Ana Claudia Latronico
Gonadotropin-dependent, or central, precocious puberty is caused by early maturation of the hypothalamic–pituitary–gonadal axis. In girls, this condition is most often idiopathic. Recently, a G protein–coupled receptor, GPR54, and its ligand, kisspeptin, were described as an excitatory neuroregulator system for the secretion of gonadotropin-releasing hormone (GnRH). In this study, we have identified an autosomal dominant GPR54 mutation — the substitution of proline for arginine at codon 386 (Arg386Pro) — in an adopted girl with idiopathic central precocious puberty (whose biologic family was not available for genetic studies). In vitro studies have shown that this mutation leads to prolonged activation of intracellular signaling pathways in response to kisspeptin. The Arg386Pro mutant appears to be associated with central precocious puberty.

27 June 2013 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AAAna Paula Abreu
Ana Paula Abreu
ADAndrew Dauber
Andrew Dauber
DMDelanie B. Macedo
Delanie B. Macedo
SNSekoni D. Noel
Sekoni D. Noel
VBVinicius N. Brito
Vinicius N. Brito
UKUrsula B. Kaiser
Ursula B. Kaiser
The onset of puberty is first detected as an increase in pulsatile secretion of gonadotropin-releasing hormone (GnRH). Early activation of the hypothalamic–pituitary–gonadal axis results in central precocious puberty. The timing of pubertal development is driven in part by genetic factors, but only a few, rare molecular defects associated with central precocious puberty have been identified. We performed whole-exome sequencing in 40 members of 15 families with central precocious puberty. Candidate variants were confirmed with Sanger sequencing. We also performed quantitative real-time polymerase-chain-reaction assays to determine levels of messenger RNA (mRNA) in the hypothalami of mice at different ages. We identified four novel heterozygous mutations in MKRN3, the gene encoding makorin RING-finger protein 3, in 5 of the 15 families; both sexes were affected. The mutations included three frameshift mutations, predicted to encode truncated proteins, and one missense mutation, predicted to disrupt protein function. MKRN3 is a paternally expressed, imprinted gene located in the Prader–Willi syndrome critical region (chromosome 15q11–q13). All affected persons inherited the mutations from their fathers, a finding that indicates perfect segregation with the mode of inheritance expected for an imprinted gene. Levels of Mkrn3 mRNA were high in the arcuate nucleus of prepubertal mice, decreased immediately before puberty, and remained low after puberty. Deficiency of MKRN3 causes central precocious puberty in humans. (Funded by the National Institutes of Health and others.)

1 February 2004 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CFChrista Fluck
Christa Fluck
TTToshihro Tajima
Toshihro Tajima
Amit V PandeyAmit V Pandey
Amit V Pandey
WAWiebke Arlt
Wiebke Arlt
KOKouji Okuhara
Kouji Okuhara
WMWalter L Miller
Walter L Miller
Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.

1 May 1994 in Nature Genetics
Verified
Journal Article
Closed access
WGWayne M. Geissler
Wayne M. Geissler
DDDaphne L. Davis
Daphne L. Davis
LWLing Wu
Ling Wu
KBKaren D. Bradshaw
Karen D. Bradshaw
SPSushma Patel
Sushma Patel
SAStefan Andersson
Stefan Andersson

1 September 1992 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ATA E Thigpen
A E Thigpen
DDD L Davis
D L Davis
AMA Milatovich
A Milatovich
BMBerenice Bilharinho Mendonca
Berenice Bilharinho Mendonca
JIJ Imperato-McGinley
J Imperato-McGinley
DRD W Russell
D W Russell
Two isozymes of steroid 5 alpha-reductase encoded by separate loci catalyze the conversion of testosterone to dihydrotestosterone. Inherited defects in the type 2 isozyme lead to male pseudohermaphroditism in which affected males have a normal internal urogenital tract but external genitalia resembling those of a female. The 5 alpha-reductase type 2 gene (gene symbol SRD5A2) was cloned and shown to contain five exons and four introns. The gene was localized to chromosome 2 band p23 by somatic cell hybrid mapping and chromosomal in situ hybridization. Molecular analysis of the SRD5A2 gene resulted in the identification of 18 mutations in 11 homozygotes, 6 compound heterozygotes, and 4 inferred compound heterozygotes from 23 families with 5 alpha-reductase deficiency. 6 apparent recurrent mutations were detected in 19 different ethnic backgrounds. In two patients, the catalytic efficiency of the mutant enzymes correlated with the severity of the disease. The high proportion of compound heterozygotes suggests that the carrier frequency of mutations in the 5 alpha-reductase type 2 gene may be higher than previously thought.